Clearblue launches first at-home menopause test: 'Personal knowledge'
The Clearblue Menopause Stage Indicator allows women to identify their likely stage of menopause: premenopause, early perimenopause, late perimenopause or postmenopause.
FDA advisers: Popular nasal decongestant ineffective for congestion relief
The leading decongestant used by millions of Americans looking for relief from a stuffy nose is likely no better than a dummy pill, according to government experts.
These are the 3 vaccines doctors hope will block fall 'tripledemic'
COVID-19 hospitalizations have been steadily increasing since late summer, and RSV already is on the rise in parts of the Southeast.
New COVID booster coming soon: Who should get it and how much will it cost?
It’s the first time since the pandemic began that the federal government won’t cover the cost of COVID-19 vaccines.
Study: Alarming surge in cancer cases among young adults
Accoring to a new study, there has been a shocking 79 percent surge in new cancer cases among people under 50, and medical experts are pointing the finger at our diets and fitness levels.
Medicare: These medications could be subject to price controls
List of 10 drugs subject to price controls to be published Sept 1
Watch: Woman meets father of heart donor who gave her new life
"I was able to marry my college sweetheart. It’s something I never thought I would live to see."
Groundbreaking AI implants help stroke victim 'talk' for first time in nearly two decades
A woman who was left unable to speak following a stroke just regained her voice, thanks to artificial intelligence.
Ozempic maker taking legal action against counterfeit copies
The drugmaker is adamant the deceptive practices not only jeopardize patient well-bein, but also compromise the credibility of their FDA-approved Semaglutide medicines.
Wagovy, Ozempic patients could face higher risk of complications under anesthesia
Drugs like Wegovy and Ozempic can slow digestion so much that it puts patients at increased risk for pulmonary aspiration when they're under anesthesia.
COVID-19 hospitalizations in the US resurge, marked by different patterns
Here we go again: COVID-19 hospital admissions have inched upward in the United States since early July in a small-scale echo of the three previous summers.
Attacks at US medical centers reveal why health care is among nation's most violent fields
Stats from the Bureau of Labor Statistics show that American health care workers are now far more likely to suffer nonfatal injuries by violence than workers in any other profession, including law enforcement.
From collapse to comeback: How Lebron James's son and Buffalo Bills safety beat the odds after cardiac arrest
What should you do if someone collapses in front of you and needs assistance?
Employers dropping weight loss drugs from insurance coverage
A new roadblock is cropping up for people on their quest to get popular weight loss drugs Ozempic and Wegovy, as more and more employers are opting to cancel insurance coverage of the pricey injection.
First Alzheimer's disease risk assessment blood test for consumers hits market
The test from Quest Diagnostics looks at a certain brain protein is known to contribute to the condition.
Tornado damage at Pfizer plant likely to cause long-term hospital drug shortages
The damaged Pfizer factory makes nearly 25% of all sterile injectable medicines used in U.S. hospitals.
Second Alzheimer's drug in pipeline can slow the disease by a few months but with safety risk
New research shows another experimental Alzheimer's drug can modestly slow patients' inevitable worsening.
'Dr. Roxy,' plastic surgeon who livestreamed on TikTok, banned from practicing medicine in Ohio
At least one patient whose surgery was livestreamed suffered severe complications and needed intense medical care after "Dr. Roxy" operated on them.
Opill, first over-the-counter birth control pill, approved by FDA
Perrigo’s once-a-day Opill will be sold without a prescription and with no age restrictions on sales.
Alzheimer’s drug Leqembi given full FDA approval
Leqembi is the first medicine that’s been convincingly shown to modestly slow the cognitive decline caused by Alzheimer's.